Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 676-700 of 781 matching filings.

Per page
25
Current page
28
S-3/A File 333-217573

S-3/A

Filing date
23 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
22 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
09 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-217573

FORM S-3

Filing date
01 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37722

CT ORDER filing

Filing date
25 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37722

DEF 14A

Filing date
21 Apr 2017
Reporting date
07 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
21 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
24 Mar 2017
Reporting date
24 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216903

S-8

Filing date
23 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
23 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
23 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37722

8-K

Filing date
06 Mar 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2017
Reporting date
16 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Feb 2017
Reporting date
15 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .